NICE recommends AstraZeneca’s dapagliflozin to treat heart failure
The UK’s NICE has issued final draft guidance recommending AstraZeneca’s dapagliflozin (Forxiga) to treat chronic heart failure.
08/25/2026
The UK’s NICE has issued final draft guidance recommending AstraZeneca’s dapagliflozin (Forxiga) to treat chronic heart failure.